Akumin is a diagnostics & research business based in the US. Akumin shares (AKU) are listed on the NASDAQ and all prices are listed in US Dollars.
Finder Award
SoFi Invest
Robinhood
tastyworks
| Latest market close | $0.89 |
|---|---|
| 52-week range | $0.46 - $2.31 |
| 50-day moving average | $0.97 |
| 200-day moving average | $1.11 |
| Wall St. target price | $3.83 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.87 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.89 from 2023-01-30
| 1 week (2023-01-20) | -9.83% |
|---|---|
| 1 month (2022-12-28) | 31.58% |
| 3 months (2022-10-31) | -49.14% |
| 6 months (2022-07-29) | 27.16% |
| 1 year (2022-01-31) | -36.88% |
|---|---|
| 2 years (2021-01-29) | -71.75% |
| 3 years (2020-01-27) | N/A |
| 5 years (2018-01-27) | N/A |
Valuing Akumin stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Akumin's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Akumin's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $132.8 million.
The EBITDA is a measure of a Akumin's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $744.4 million |
|---|---|
| Operating margin TTM | 4.47% |
| Gross profit TTM | $93.6 million |
| Return on assets TTM | 1.11% |
| Return on equity TTM | -45.91% |
| Profit margin | -19.73% |
| Book value | $-0.08 |
| Market capitalisation | $87 million |
TTM: trailing 12 months
We're not expecting Akumin to pay a dividend over the next 12 months.
Over the last 12 months, Akumin's shares have ranged in value from as little as $0.464 up to $2.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akumin's is 0.8892. This would suggest that Akumin's shares are less volatile than average (for this exchange).
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
